Penumbra, Inc. (PEN)
321.03
-0.82
(-0.25%)
USD |
NYSE |
Nov 10, 10:00
Penumbra Cash and Short Term Investments (Quarterly) : 673.61M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 673.61M |
| June 30, 2026 | 658.80M |
| March 31, 2026 | 615.66M |
| December 31, 2025 | 544.82M |
| September 30, 2025 | 470.30M |
| June 30, 2025 | 424.56M |
| March 31, 2025 | 378.85M |
| December 31, 2024 | 340.13M |
| September 30, 2024 | 291.02M |
| June 30, 2024 | 339.70M |
| March 31, 2024 | 313.47M |
| December 31, 2023 | 289.19M |
| September 30, 2023 | 248.86M |
| June 30, 2023 | 221.06M |
| March 31, 2023 | 199.10M |
| December 31, 2022 | 188.03M |
| September 30, 2022 | 184.43M |
| June 30, 2022 | 204.37M |
| March 31, 2022 | 240.34M |
| December 31, 2021 | 254.88M |
| September 30, 2021 | 266.93M |
| June 30, 2021 | 239.00M |
| March 31, 2021 | 242.61M |
| December 31, 2020 | 264.83M |
| Date | Value |
|---|---|
| September 30, 2020 | 268.73M |
| June 30, 2020 | 278.30M |
| March 31, 2020 | 168.22M |
| December 31, 2019 | 189.39M |
| September 30, 2019 | 194.44M |
| June 30, 2019 | 187.26M |
| March 31, 2019 | 194.85M |
| December 31, 2018 | 200.89M |
| September 30, 2018 | 193.92M |
| June 30, 2018 | 206.89M |
| March 31, 2018 | 215.44M |
| December 31, 2017 | 214.59M |
| September 30, 2017 | 218.82M |
| June 30, 2017 | 220.46M |
| March 31, 2017 | 233.34M |
| December 31, 2016 | 128.75M |
| September 30, 2016 | 141.83M |
| June 30, 2016 | 139.86M |
| March 31, 2016 | 144.42M |
| December 31, 2015 | 148.80M |
| September 30, 2015 | 159.10M |
| June 30, 2015 | 36.76M |
| March 31, 2015 | 47.60M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Boston Scientific Corp. | 667.00M |
| Teleflex, Inc. | 439.14M |
| Integra LifeSciences Holdings Corp. | 311.93M |
| Globus Medical, Inc. | 517.44M |
| Abbott Laboratories | 4.298B |